With cancer affecting a significant portion of the global population, conventional treatments often bring challenging side effects and aren't always fully effective, leading many patients to seek complementary therapies. Traditional Chinese Medicine (TCM) and its herbal remedies are emerging as a valuable integrated approach. Research highlights several TCM herbs with anti-cancer properties, potentially aiding prevention and symptom management by boosting immunity, reducing inflammation, and targeting cancer pathways. Examples include huang qi (astragalus) for enhancing anti-tumor effects, ren shen (ginseng) to reduce fatigue and inhibit cancer cell growth, and jiang huang (turmeric) for its anti-inflammatory benefits and potential in prostate cancer.

Herbal solutions address critical unmet symptom needs like pain and fatigue. Programs like the one at Memorial Sloan Kettering Cancer Center (MSKCC) demonstrate successful integration, reporting significant symptom relief in over 70% of participants with minimal adverse effects when supervised by licensed practitioners. Furthermore, studies in Taiwan suggest TCM herbs like danggui may have a preventative effect for breast cancer when combined with hormonal therapy and can be associated with improved survival rates alongside conventional treatments. While research is growing, collaboration between medical professionals and TCM practitioners is crucial to advance evidence-based integration and improve global cancer outcomes.